A pan-cancer analysis of the prognostic and immunological role of β-actin (ACTB) in human cancers. Issue 1 (1st January 2021)

• Record Type: Journal Article
• Authors: Gu, Yuxi; Tang, Shouyi; Wang, Zhen; Cai, Luyao; Lian, Haosen; Shen, Yingqiang; Zhou, Yu
• Is Part Of: Bioengineered. Volume 12:Issue 1(2021)
• Page Start: 6166
• Page End: 6185
• Publication Date: 2021-01-01
• Subjects: ACTB -- biomarker -- pan-cancer -- prognosis -- immune analysis -- functional relevance; Biomedical engineering -- Periodicals; Biotechnology -- Periodicals; Microbiology -- Periodicals; 660.6
• DOI: 10.1080/21655979.2021.1973220
• Languages: English
• ISSNs: 2165-5987

Abstract

ABSTRACT: Beta-actin (ACTB), a highly conserved cytoskeleton structural protein, has been regarded as a common housekeep gene and used as a reference gene for years. However, accumulating evidence indicates that ACTB is abnormally expressed in multiple cancers and hence changes the cytoskeleton to affect the invasiveness and metastasis of tumors. This study aimed to investigate the function and clinical significance of ACTB in pan-cancer. The role of ACTB for prognosis and immune regulation across 33 tumors was explored based on the datasets of gene expression omnibus and the cancer genome atlas. Differential expression of ACTB was found between cancer and adjacent normal tissues, and significant associations was found between ACTB expression and prognosis of tumor patients. In most cancers, ACTB expression was associated with immune cells infiltration, immune checkpoints and other immune modulators. Relevance between ACTB and metastasis and invasion was identified in various types of cancers by CancerSEA. Moreover, focal adhesion and actin regulation-associated pathways were included in the functional mechanisms of ACTB. The expression of ACTB was verified by quantitative real-time polymerase chain reaction. Knockdown of ACTB inhibited head and neck squamous carcinoma cell migration and invasion by NF-κB and Wnt/β-catenin pathways. Our first pan-cancer study of ACTB offers insight into the prognostic and immunological roles of ACTB across different tumors, indicating ACTB may be a potential biomarker for poor prognosis and immune infiltration in cancers, and the role of ACTB as a reference gene in cancers was challenged.